Skip to main navigation
Verastem, Inc.

    Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request
  • Our Science
    • Pipeline
    • KRAS G12D Inhibition
    • RAF / MEK / FAK Inhibition
    • Clinical Trials
      • TARGET-D 201
      • TARGET-D 202
      • TARGET-D 203
    • Resources
  • Our Medicines
  • Medical Professionals
    • Overview
    • HCP Resources
      • Request Medical Information
      • Medical Education Grants and Scholarships
      • Investigator Sponsored Trials
      • Expanded Access
  • Patients & Advocacy
  • Investors & Media

    Investor Relations

    • Overview
    • News & Media
      • Press Releases
      • Media Resources
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • IR Resources

    • Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request

Event Details

Verastem Oncology VS-7375 R&D Update

Oct 14, 2026 at 8:00 AM EDT

Webcast Presentation

  • Listen to webcast
Event Details
Title
Verastem Oncology VS-7375 R&D Update
Date / Time
Oct 14, 2026 at 8:00 AM EDT
Add to Outlook
Add to Google Calendar
  • Terms of Use
  • Compliance & Ethics
  • Copyright Statement
  • Privacy Policy
  • Contact
  • Sitemap
Twitter Linkedin
Verastem logo

© 2026 Verastem, Inc. All Rights Reserved.